Concepedia

Deepti Satelli

DS

Statistics

Publications

3

Citations

324

H-Index

3

Active since

2020

Affiliations

The University of Kansas Cancer Center(Current)

University of Kansas Medical Center

Peter MacCallum Cancer Centre

GZA Ziekenhuizen Campus Sint-Augustinus

Deepti Satelli is an author at The University of Kansas Cancer Center specializing in neoadjuvant anthracycline-based therapy, anthracycline-based chemotherapy, and adjuvant therapy.

Publications per year

2020–2023

3

Publications

3

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · JAMA Oncology · 2023 · 164 citations · Full text

, , +17

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

, , +17

Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · Journal of Clinical Oncology · 2022 · 51 citations

, , +13

1–3 of 3